Borrelia burgdorferi infection and Lyme disease in children

International Journal of Infectious Diseases

Volumn 17, Issue 3, 2013, Pages

  Esposito, Susanna ^a   Bosis, Samantha ^a   Sabatini, Caterina ^a   Tagliaferri, Laura ^a   Principi, Nicola ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Borrelia burgdorferi; Erythema migrans; Heart borreliosis; Lyme arthritis; Lyme disease; Lyme meningitis; Neuroborreliosis

Indexed keywords

AMOXICILLIN; AZITHROMYCIN; CEFOTAXIME; CEFTRIAXONE; CEFUROXIME AXETIL; CLARITHROMYCIN; DOXYCYCLINE; ERYTHROMYCIN; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; PENICILLIN G; PENICILLIN V;

ARTHRALGIA; ARTIFICIAL VENTILATION; ATAXIA; BORRELIA INFECTION; CARDITIS; CLINICAL FEATURE; DIAGNOSTIC TEST; ELECTROCARDIOGRAPHY; ERYTHEMA CHRONICUM MIGRANS; FACIAL NERVE PARALYSIS; HEART BLOCK; HUMAN; JUVENILE RHEUMATOID ARTHRITIS; LYME DISEASE; LYMPHOCYTOMA; REVIEW; SINGLE DRUG DOSE; SYMPTOM; TREATMENT OUTCOME; VERTICAL TRANSMISSION;

ANIMALS; ANTIBODIES, BACTERIAL; ARACHNID VECTORS; BORRELIA BURGDORFERI; CHILD; FEMALE; HUMANS; LYME DISEASE; MALE; TICKS;

EID: 84874486494     PISSN: 12019712     EISSN: 18783511     Source Type: Journal    
DOI: 10.1016/j.ijid.2012.09.014     Document Type: Review

References (49)

1. Shapiro E.D., Gerber M.A. Lyme disease. Clin Infect Dis 2000, 31:533-542.
2. Bacon R.M., Kugeler K.J., Mead P.S. Surveillance for Lyme disease-United States, 1992-2006. MMWR Surveill Summ 2008, 57:1-9.
3. Rizzoli A., Hauffe H.C., Carpi G., Vourc'h G.I., Neteler M., Rosà E. Lyme borreliosis in Europe. Euro Surveill 2011, 16. pii: 19906.
4. Stanek G., Wormser G.P., Gray J., Strle F. Lyme borreliosis. Lancet 2012, 379:461-473.
5. Christen H.J., Hanefeld F., Eiffert H., Thomsen R. Epidemiology and clinical manifestations of Lyme borreliosis in childhood. A prospective multicentre study with special regard to neuroborreliosis. Acta Paediatr 1993, 82(Suppl):1-75.
6. Skogman B.H., Ekerfelt C., Ludvigsson J., Forsberg P. Seroprevalence of Borrelia IgG antibodies among young Swedish children in relation to reported tick bites, symptoms and previous treatment for Lyme borreliosis: a population-based survey. Arch Dis Child 2010, 95:1013-1016.
7. Feder H.M., Gerber M.A., Cartter M.L., Sikand V., Krause P.J. Prospective assessment of Lyme disease in a school-aged population in Connecticut. J Infect Dis 1995, 171:1371-1374.
8. Weiner H.R. Lyme disease. Questions and discussion. Comp Ther 2006, 32:17-19.
9. Aguero-Rosenfeld M.E., Wang G., Schwartz I., Wormser G.P. Diagnosis of Lyme borreliosis. Clin Microbiol Rev 2005, 18:484-509.
10. Skogman B.H., Hellberg S., Ekerfelt C., Jenmalm M.C., Forsberg P., Ludvigsson J., et al. Adaptive and innate immune responsiveness to Borrelia burgdorferi sensu lato in exposed asymptomatic children and children with previous clinical Lyme borreliosis. Clin Dev Immunol 2012, 2012:294587.
11. Gerber M.A., Shapiro E.D., Burke G.S., Parcells V.J., Bell G.L. Lyme disease in children in southeastern Connecticut. Pediatric Lyme Disease Study Group. N Engl J Med 1996, 335:1270-1274.
12. Steere A.C. Lyme disease. N Engl J Med 1989, 321:586-596.
13. ArneŽ M., RuŽić-Sabljić E. Borrelia burgdorferi sensu lato bacteremia in Slovenian children with solitary and multiple erythema migrans. Pediatr Infect Dis J 2011, 30:988-990.
14. Maraspin V., Ogrinc K., RuŽić-Sabljić E., Lotrič-Furlan S., Strle F. Isolation of Borrelia burgdorferi sensu lato from blood of adult patients with borrelial lymphocytoma, Lyme neuroborreliosis, Lyme arthritis and acrodermatitis chronica atrophicans. Infection 2011, 39:35-40.
15. Wormser G.P., Dattwyler R.J., Shapiro E.D., John J., Halperin J.J., Steere A.C., et al. The clinical assessment, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis 2006, 43:1089-1134.
16. ArneŽ M., Radsel-Medvescek A., Pleterski-Rigler D., Ruzić-Sabljić E., Strle F. Comparison of cefuroxime axetil and phenoxymethyl penicillin for the treatment of children with solitary erythema migrans. Wien Klin Wochenschr 1999, 111:916-922.
17. ArneŽ M., Pleterski-Rigler D., Luznik-Bufon T., Ruzić-Sabljić E., Strle F. Solitary erythema migrans in children: comparison of treatment with azithromycin and phenoxymethylpenicillin. Wien Klin Wochenschr 2002, 114:498-504.
18. Strle F., Pleterski-Rigler D., Stanek G., Pejovnik-Pustinek A., Ruzic E., Cimperman J. Solitary borrelial lymphocytoma: report of 36 cases. Infection 1992, 20:201-206.
19. Wilke M., Eiffert H., Christen H.J., Hanefeld F. Primarily chronic and cerebrovascular course of Lyme neuroborreliosis: case reports and literature review. Arch Dis Child 2000, 83:67-71.
20. Cook S.P., Macartney K.K., Rose C.D., Hunt P.G., Eppes S.C., Reilly J.S. Lyme disease and seventh nerve paralysis in children. Am J Otolaryngol 1997, 18:320-323.
21. Belman A.L., Iyer M., Coyler P.K., Dattwyler R. Neurologic manifestations in children with North American Lyme disease. Neurology 1993, 43:2609-2614.
22. Tveitnes D., Oymar K., Natas O. Acute facial nerve palsy in children: how often is it Lyme borreliosis?. Scand J Infect Dis 2007, 39:425-431.
23. Nigrovic L.E., Thompson A.D., Fine A.M., Kimia A. Clinical predictors of Lyme disease among children with a peripheral facial palsy at an emergency department in a Lyme disease-endemic area. Pediatrics 2008, 122. e1080-5.
24. Salinas R.A., Alvarez G., Ferreira J. Corticosteroids for Bell's palsy (idiopathic facial paralysis). Cochrane Database Syst Rev 2004, 4:CD001942.
25. Allen D., Dunn L. Acyclovir or valaciclovir for Bell's palsy (idiopathic facial paralysis). Cochrane Database Syst Rev 2004, 3:CD001869.
26. Fine A.M., Brownstein J.S., Nigrovic L.E., Kimia A.A., Olson K.L., Thompson A.D., et al. Integrating spatial epidemiology into a decision model for evaluation of facial palsy in children. Arch Pediatr Adolesc Med 2011, 165:61-67.
27. Bremell D., Hagberg L. Clinical characteristics and cerebrospinal fluid parameters in patients with peripheral facial palsy caused by Lyme neuroborreliosis compared with facial palsy of unknown origin (Bell's palsy). BMC Infect Dis 2011, 11:215.
28. Skogman B.H., Croner S., Nordwall M., Eknefelt M., Ernerudh J., Forsberg P. Lyme neuroborreliosis in children: a prospective study of clinical features, prognosis, and outcome. Pediatr Infect Dis J 2008, 27:1089-1094.
29. Vázquez M., Sparrow S.S., Shapiro E.D. Long-term neuropsychologic and health outcomes of children with facial nerve palsy attributable to Lyme disease. Pediatrics 2003, 112. e93-7.
30. Garro A.C., Rutman M.A., Simonsen K., Jager J.L., Chapin K., Lockhart G. Prevalence of Lyme meningitis in children with aseptic meningitis in a Lyme disease-endemic region. Pediatr Infect Dis J 2011, 30:990-992.
31. Halperin J.J., Shapiro E.D., Logigian E., Belman A.L., Dotevall L., Wormser G.P., et al. Practice parameter: treatment of nervous system Lyme disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2007, 69:91-102.
32. Cohn K.A., Thompson A.D., Shah S.S., Hines E.M., Lyons T.W., Welsh E.J., et al. Validation of a clinical prediction rule to distinguish Lyme meningitis from aseptic meningitis. Pediatrics 2012, 129:e46-e53.
33. Garro A.C., Rutman M., Simonsen K., Jaeger J.L., Chapin K., Lockhart G. Prospective validation of a clinical prediction model for Lyme meningitis in children. Pediatrics 2009, 123:e829-e834.
34. Tuerlinckx D., Bodart E., Jamart J., Glupczynski Y. Prediction of Lyme meningitis based on a logistic regression model using clinical and cerebrospinal fluid analysis: a European study. Pediatr Infect Dis J 2009, 28:394-397.
35. Berglund J., Stjernberg L., Ornstein K., Tykesson-Joelsson K., Walter H. 5-y follow-up study of patients with neuroborreliosis. Scand J Infect Dis 2002, 34:421-425.
36. Fish A.E., Pride Y.B., Pinto D.S. Lyme carditis. Infect Dis Clin North Am 2008, 22:275-288.
37. Costello J.M., Alexander M.E., Greco K.M., Perez-Atayde A.R., Laussen P.C. Lyme carditis in children: presentation, predictive factors, and clinical course. Pediatrics 2009, 123. e835-41.
38. Feder H.M., Abeles M., Bernstein M., Whitaker-Worth D., Grant-Kels J.M. Diagnosis, treatment and prognosis of erythema migrans and Lyme arthritis. Clin Dermatol 2006, 24:509-520.
39. Gerber M.A., Zemel L.S., Shapiro E.D. Lyme arthritis in children: clinical epidemiology and long-term outcomes. Pediatrics 1998, 102:905-908.
40. Thompson A., Mannix R., Bachur R. Acute pediatric monoarticular arthritis: distinguishing Lyme arthritis from other etiologies. Pediatrics 2009, 123:959-965.
41. Szer I.S., Taylor E., Steere A.C. The long-term course of Lyme arthritis in children. N Engl J Med 1991, 325:159-163.
42. Bentas W., Karch H., Huppertz H.I. Lyme arthritis in children and adolescents: outcome 12 months after initiation of antibiotic therapy. J Rheumatol 2000, 27:2025-2030.
43. Tory H.O., Zurakowski D., Sundel R.P. Outcomes of children treated for Lyme arthritis: results of a large pediatric cohort. J Rheumatol 2010, 37:1049-1055.
44. Taber L.H., Feigin L.D. Spirochetal infections. Pediatr Clin North Am 1979, 26:377-413.
45. MacDonald A.B., Benach J.L., Burgdorfer W. Still birth following maternal Lyme disease. N Y State J Med 1987, 87:615-616.
46. Weber K., Bratzke H.J., Neubert U., Wilske D., Duray P.K. Borrelia burgdorferi in a newborn despite oral penicillin for Lyme borreliosis during pregnancy. Pediatr Infect Dis J 1988, 7:286-289.
47. Maraspin V., RuŽić-Sabljić E., Pleterski-Rigler D., Strle F. Pregnant women with erythema migrans and isolation of borreliae from blood: course and outcome after treatment with ceftriaxone. Diagn Microbiol Infect Dis 2011, 71:446-448.
48. Fryland L., Wilhelmsson P., Lindgren P.E., Nyman D., Ekerfelt C., Forsberg P. Low risk of developing Borrelia burgdorferi infection in the south-east of Sweden after being bitten by a Borrelia burgdorferi-infected tick. Int J Infect Dis 2011, 15:e174-e181.
49. Warshafsky S., Lee D.H., Francois L.K., Nowakowski J., Nadelman R.B., Wormser G.P. Efficacy of antibiotic prophylaxis for the prevention of Lyme disease: an updated systematic review and meta-analysis. J Antimicrob Chemother 2010, 65:1137-1144.